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Abstract
Methods The study included 25 hypertrophic car-
diomyopathy (HCM) patients (15 non-obstructive
and 10 obstructive) and 25 controls for assessment of
left atrial (LA) volume, mass and function by two-
dimensional echocardiography. Measurement in-
c l u d e d m e a n L A d i a m e t e r ( L A D ) , L A
mass = {(mean LAD + anterior LA wall + posterior
LA wall)3  mean LAD3} · 0.8 + 0.6, LA volume =
[(8/3 p L  A1  A2), where L is LA length, A1 and
A2 are LA area in 4-chambers and 2-chambers,
respectively] including maximum (Vmax), minimum
(Vmin), and pre-atrial contraction (Vpre-A), total atrial
stroke volume (TA-SV), TA emptying fraction (TA-
EF), active atrial SV (AA-SV), AA-EF, passive atrial
SV (PA-SV), PA-EF, atrial expansion index (AEI),
and LA kinetic energy (LA-KE) = ½ · AA-
SV · P · V2.
Results LAD, LA mass, Vmax, Vmin, and Vpre-A were
significantly higher in HCM than controls. TA-SV
and TA-EF were comparable in both HCM subgroups
and controls. AA-SV and LA-KE were significantly
higher in both HCM subgroups than controls. LA-KE
was significantly higher in obstructive HCM than
non-obstructive (P < 0.001). PA-EF and AEI were
significantly lower in obstructive HCM than controls
(P < 0.05).
Conclusion HCM is associated with increased LA
size and augmented LA pump function especially
obstructive type. LA conduit and reservoir functions
are impaired in obstructive HCM.
Keywords Left atrial function  Hypertrophic
cardiomyopathy  Left atrial volume  Left atrial mass
Introduction
Hypertrophic cardiomyopathy (HCM) is a relatively
common form of genetic heart disease affecting
approximately 1 in 500 in the general population [1,
2]. The pathophysiologic appearance of HCM is
complex and includes dynamic left ventricular out-
flow tract (LVOT) obstruction, mitral regurgitation,
diastolic dysfunction, myocardial ischemia and car-
diac arrhythmia [3]. Diastolic dysfunction is more
common than systolic dysfunction in HCM due to
marked left ventricular hypertrophy, interstitial fibro-
sis and myocardial ischemia. These factors contribute
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to elevated left atrial (LA) and pulmonary vascular
pressures [4]. LA modulates left ventricular filling
through three components, a phase of reservoir
component or expansion during systole, a conduit
phase during diastole and an active contractile
component during late diastole [5]. The active LA
contraction has an important role in patients with
reduced left ventricular compliance as it is compen-
sating the decreased early filling [6, 7]. In HCM,
stiffness of LA increases and this affects its reservoir
function and may in turn affects the cardiac output
[8]. LA enlargement is a common findings in HCM
and associated with increased morbidity and mortal-
ity [9, 10]. The present study aimed to assess LA size,
mass and function in HCM patients compared with
normal subjects.
Patients and methods
A retrospective study included 25 patients (80%
males, mean age 38 ± 15 years) with an established
diagnosis of HCM [11] and good two-dimensional
echocardiography (2DE) image quality. According to
the type of HCM, patients were classified into two
groups the non-obstructive group included 15 patients
with resting LVOT gradient <30 mm Hg, and the
obstructive group included 10 patients with resting
LVOT gradient 30 mm Hg. A group of 25 normal
age-matched adults (mean age 35 ± 16 years) served
as control subjects. None of them had evidence of
cardiovascular disease by clinical examination, rest-
ing ECG and echocardiographic examination.
2DE was undertaken for HCM patients and control
subjects with lying in the left lateral decubitus using
both apical and parasternal views. 2DE studies were
performed using a 3.5 MHz transducer and a
commercially available ultrasound system (Philips
Sonos 7500, Best, The Netherlands). The following
measures were obtained.
Left ventricular (LV) function
LV fractional shortening and ejection fraction were
selected as a marker for systolic function. LV end-
diastolic (LV-EDD) and end-systolic (LV-ESD)
dimensions were measured using M-mode from
parasternal long axis view and thus LV fractional
shortening were calculated by the traditional formula:
Fractional shortening (%) = [LV-EDD  LV-ESD]/
LV-EDD%. LV end-diastolic (LV-EDV) and end-
systolic (LV-ESV) volumes were measured by 2D
biplane modified Simpson’s method and then ejection
fraction was calculated by the formula: Ejection
fraction = [LV-EDVLV-ESV]/LV-EDV. Transmi-
tral E/A ratio was defined by pulsed wave Doppler
and used as a marker of LV diastolic function.
Mitral regurgitation
Mitral regurgitation was defined by colour Doppler
and graded according to the maximum regurgitant jet
area as mild (jet area <4 cm2), moderate (jet area 4–
8 cm2), and severe (jet area >8 cm2) [12]
LA diameter (LAD)
Maximum LAD was measured at three planes:
antero-posterior from parasternal long axis view,
medial-lateral and superior-inferior from apical four-
chamber view. Then mean LAD (mean LAD) was
defined as the average of the three LAD (See Fig. 1)
Fig. 1 Measurement of
maximum left atrial
diameter (LAD) at three
planes: (A) antero-posterior
LAD from parasternal long
axis view, (B) medial-
lateral LAD and (c)
superior-inferior LAD from
apical four-chamber view
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LA mass
LA mass was calculated with the same formula
applied for left ventricular mass [13] {(mean
LAD + anterior LA wall + posterior LA
wall)3  mean LAD3} · 0.8 + 0.6. Thickness of
anterior and posterior LA walls was measured from
parasternal long axis view. Zooming was used to
discriminate between posterior LA wall and pericar-
dium (See Fig. 2)
LA volume (LAV)
LAV was assessed according to the formula [6] 8/
3 p L · A1 · A2 where (L) is the LA longitudinal axis
and (A1) is LA area at apical four-chamber and (A2) at
apical two-chamber views. (L) was defined as the
perpendicular line from mid point of the mitral valve
plane to the tip of LA apex (See Fig. 3). LA area was
obtained by manual tracing of LA endocardial border
excluding LA appendage and the pulmonary veins
when visualized. The superior border of atrial outline
was a straight line connecting both sides of the leaflet
base attachment points. LAV was calculated at three
phases of ventricular cardiac cycle: maximum LAV
(V max) at the end-systole just before mitral valve
opening, minimum LAV (V min) at end-diastole just
before mitral valve closure, and LAV before atrial
contraction (V Pre-A): the last frame before mitral valve
reopening. From the three LAV, the following
measurements were selected as indices of LA function
and calculated according to previous studies [14, 15]:
(1) Total Atrial Stroke Volume (TA-SV) defined
as Vmax  Vmin, 2) Total Atrial Emptying Fraction
(TA-EF) defined as TA-SV/Vmax · 100%, 3) Active
Atrial Stroke Volume (AA-SV) defined as
VPre A  Vmin, 4) Active Atrial Emptying Fraction
(AA-EF) defined as AA-SV/VPre A · 100%, 5) Atrial
Expansion Index (AEI) defined as TA-SV/
Vmin · 100%, 6) Passive Atrial Stroke Volume (PA-
SV) defined as Vmax  VPre A, and 7) Passive Atrial
Emptying Fraction (PA-EF) defined as (Vmax  VPre A)/
Vmax · 100%.
LA kinetic energy (LA-KE)
LA-KE [16] was calculated according to the formula
½ · AA-SV · P · V2, where P = 1.06 g cm3 (blood
density), and (V) is the peak velocity of transmitral A
wave was measured by pulsed wave Doppler.
To characterize the three phases of LA activity,
PA-SV and PA-EF were defined as indices for LA
conduit function, AA-SV, AA-EF, and LA-KE for
LA pump function, and AEI for LA reservoir
function.
Statistical analysis
All values were expressed as mean ± SD. Paired t-test
was used for comparison between all HCM patients
and controls. Independent sample t-test was used for
comparison between both HCM subgroups and
between each HCM subgroup and controls. The
difference in the values between groups was consid-
ered significant if P value < 0.05. The statistical
package used was SPSS version 12.1.
Results
Baseline criteria (See Table 1)
Both HCM patient group and controls were compa-
rable with respect to age and sex distribution. All
patients and controls were in sinus rhythm (mean
heart rate 72 ± 13 beat per minute) and had normal LV
Fig. 2 M-mode obtained
from parasternal long axis
view (A). Zooming was
used to measure anterior left
atrial wall (B) and posterior
left atrial
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systolic function. All HCM patients had type I
diastolic dysfunction (increased A velocity, with an
E/A ratio <1) [17]. Twenty patients (80%) were under
medications (10 patients under Verapamil, six under
b-blockers, four under Amiodarone). LV-ESD and
LV-ESV were significantly smaller in HCM patients
than controls, while LV-EDD and LV-EDV showed
no difference. LV-FS and LV-EF were significantly
higher in HCM patients than controls (P = 0.001).
HCM patients had a higher mean transmitral peak A
velocity (61.5 ± 20.3 vs. 39.7 ± 9.9 cm/s, P < 0.01).
The prevalence and severity of mitral regurgitation
were significantly higher in HCM patients compared
to controls as 80% of HCM patients had mitral
regurgitation (60% mild and 20% moderate to severe),
while 20% of controls had mild mitral regurgitation
(P < 0.0001). Both HCM patient subgroups (obstruc-
tive and non-obstructive) showed no significant
differences in LV dimensions, volumes and function.
Also, no significant difference in the prevalence and
severity of mitral regurgitation was present.
LA size and mass (Table 1)
The maximum LAD at the three planes and the mean
LAD were significantly larger in HCM patients than
controls (P < 0.001). Thickness of anterior and posterior
LA walls showed no significant differences between
HCM patients and controls. LA mass was significantly
higher in HCM patients than controls (89.8 ± 37.2 vs.
32.3 ± 12.0 g, P < 0.0001). No significant differences
were found between HCM patient subgroups in the
mean LAD, wall thickness and LA mass.
LAV and total LA function (Table 2)
LAV at the three phases of cardiac cycle (Vmax, Vmin,
and VPre-A) was significantly higher in both HCM
patient subgroups than control group. TA-SV, TA-EF
showed no significant differences between both HCM
patient subgroups and control group. Vmax was well
correlated with the mean LAD (r = 0.89, P < 0.0001).
LA pump function
AA-EF showed no significant differences between
both HCM patient subgroups and control group,
while AA-SV was significantly higher in both HCM
patient subgroups than control group (12.0 ± 6.2 ml,
11.4 ± 6.5 ml vs. 7.3 ± 4.0 ml, P < 0.001). No
significant differences were found between HCM
patient subgroups in AA-EF and AA-SV. LA-KE was
significantly higher in HCM patients than controls
(24.3 ± 18.9 vs. 11.9 ± 7.4 kdynes cm, P = 0.002).
Fig. 3 Calculation of LAV
using 2DE by manual tracing
of LA endocardial border at
apical four-chamber (A1)
and apical two chamber
views (A2), L is the long
axis, then apply the formula.:
8/3 p L · A1 · A2
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Table 1 Baseline clinical and echocardiographic data of HCM patients and controls
HCM patients N = 25 Normal control n = 25 P value
Age (yr) 38 ± 15 35 ± 15
Male gender (%) 24 (80%) 18 (60%)
Left ventricular FS (%) 38.4 ± 9.6 30.3 ± 5.4 0.03
Left ventricular EF (%) 71.1 ± 17.7 57.4 ± 1.0 0.001
Peak A velocity (cm/s) 61.5 ± 20.3 39.7 ± 9.9 0.01
Mitral regurgitation
No 5 (20%) 24 (80 %) 0.0001
Mild 15 (60%) 6 (20%)
Moderate-severe 5 (20%) 0 (0%)
Antero-posterior LAD (mm) 42.8 ± 5.8 34.1 ± 4.2 0.0001
Medial-lateral LAD (mm) 45.6 ± 9.9 36.2 ± 3.8 0.001
Superior-inferior LAD (mm) 60.8 ± 9.0 44.8 ± 6.7 0.0001
Mean LAD (mm) 49.7 ± 7.2 38.4 ± 4.0 0.0001
Anterior left atrial wall (mm) 3.6 ± 1.0 3.5 ± 1.0 NS
Posterior left atrial wall (mm) 3.5 ± 1.2 3.1 ± 1.1 NS
Left atrial mass (g) 89.8 ± 37.2 47.8 ± 18.1 0.0001
Abbreviations: FS fractional shortening, EF ejection fraction, and LAD left atrial diameter
Table 2 Left atrial mass and function in non-obstructive HCM and obstructive HCM patients
Normal control n = 25 Non-obstructive HCM n = 15 Obstructive HCM n = 10 P value
* **
Mean LAD (mm) 38.4 ± 4.0 49.6 ± 7.6 49.9 ± 7.0 0.0001 0.0001
LA mass (g) 47.8 ± 18.1 86.8 ± 41.1 93.9 ± 32.5 0.002 0.001
V max (ml) 38.2 ± 10.7 64.7 ± 26.7 65.9 ± 28.1 0.002 0.009
V min (ml) 17.4 ± 7.6 32.7 ± 22.1 37.1 ± 19.7 0.02 0.008
V pre A (ml) 24.9 ± 7.7 44.7 ± 24.7 48.5 ± 21.5 0.008 0.005
TA-SV (ml) 20.5 ± 6.9 32.0 ± 8.9 28.8 ± 13.1 NS NS
TA-EF (%) 54.7 ± 14.2 53.6 ± 13.8 45.4 ± 12.8 NS NS
AA-SV (ml) 7.3 ± 4.0 12.0 ± 6.2 11.4 ± 6.5 0.001 0.001
AA-EF (%) 31.4 ± 17.8 29.7 ± 13.5 25.4 ± 12.8 NS NS
LA-KE (kdynes.cm) 11.9 ± 7.4 18.3 ± 12.5 32.5 ± 23.3a 0.03 0.001
PA-SV (ml) 13.4 ± 5.7 20.0 ± 8.8 17.5 ± 9.8 0.02 NS
PA-EF (%) 33.9 ± 10.1 34.0 ± 14.8 27.1 ± 7.0 NS 0.03
AEI (%) 141.7 ± 74.0 134.8 ± 74.4 91.1 ± 39.7 NS 0.02
Abbreviations: see text
* P value between non-obstructive HCM patients and controls
** P value between obstructive HCM patients and controls
a P value < 0.001 between obstructive and non-obstructive HCM patients
Int J Cardiovasc Imaging (2008) 24:45–52 49
123
LA-KE was significantly higher in obstructive HCM
patients than non-obstructive patients (32.5 ± 23.3 vs.
18.3 ± 12.5 kdynes cm, P < 0.001).
LA conduit function
PA-SV was significantly increased in HCM patients
than controls (18.9 ± 9.2 vs. 13.4 ± 5.7 ml, P = 0.01).
PA-SV was significantly higher in non-obstructive
HCM patients than controls (20.0 ± 8.8 vs.
13.4 ± 5.7 ml, P = 0.02), while in obstructive HCM
patients; it was comparable to controls (17.5 ± 9.8
vs.13.4 ± 5.7 ml). PA-EF showed no significant
difference between HCM patients and controls. PA-EF
was significantly lower in obstructive HCM patients
than controls (27.1 ± 7.0 vs. 33.9 ± 10.1, P = 0.02), while
in non-obstructive HCM patients; it was comparable to
controls (34.0 ± 14.8 vs. 33.9 ± 10.1).
LA reservoir function
AEI showed no significant difference between HCM
patients and controls. AEI was comparable in non-
o bs t ru c t iv e HCM pat i e n t s a nd co n t r o l s
(134.8 ± 74.4% vs. 141.7 ± 74.0%, P=NS) but it
was significantly lower in obstructive HCM patients
than controls (91.1 ± 39.7% vs. 141.7 ± 74.0%,
P = 0.02).
Discussion
In the present study, LA size was increased in HCM
patients as assessed by LA dimension at three
directions (antero-posterior, medial-lateral and supe-
rior-inferior) and by LAV at three phases of cardiac
cycle. Thus, LA mass was increased in HCM patients
compared to normal subjects. According to Frank–
Starling mechanism, LA pump function in HCM was
increased to help ventricular filling as shown by
increased AA-SV and LA-KE. LA reservoir and
conduit functions were decreased in obstructive HCM
patients as shown by decreased AEI and PA-EF. The
clinical importance of this study is the close
relationship of LA dimension and function with the
development of serious complications as atrial fibril-
lation, cerebral infarction, and progressive heart
failure in HCM as shown in previous studies [18–
20] as well as adverse outcome after myectomy [21]
The previous studies describing LA changes in
HCM identified increased LAV [22, 23]. LA
responds to the increased LAV by linear increase of
LAD as shown in the present study. The nonlinear
correlation between the increased LAD and increased
LAV in previous studies [24] may be due to
unidimensional M-mode assessment of LA size
while, in the present study, the LA size was relied
on 2D multidimensional assessment and the mean LA
dimension was comparable to previous studies [10,
25].
The increased left ventricular wall thickness and
elevated filling pressure in HCM frequently lead to
development of abnormal diastolic function. In
response to this overload, LA contractility increases
to maintain adequate left ventricular filling. In
accordance with previous studies [26, 27], AA-SV
and LA-KE was significantly increased in our HCM
patients than controls. Other studies reported no
increase in LA contractility [28, 29]. The discrepancy
between studies describing LA contractility in HCM
is due to difference in hemodynamic conditions,
atrio-ventricular interaction and left ventricular sys-
tolic function.
In HCM patients, the rate of left ventricular
relaxation deteriorates due to markedly thickened
and non-compliant left ventricle, which led to
deterioration of LA conduit function. This was
expressed by reduction in PA-EF in our HCM
patients compared to controls.
LA reservoir function is determined by LA
relaxation and mitral annulus displacement during
left ventricular contraction [30]. In accordance with
previous studies [8], AEI was significantly reduced in
obstructive HCM patients, which indicates impaired
LA relaxation. AEI showed no difference between
our non-obstructive HCM patients and controls
indicating preserved LA reservoir function.
Study limitation
The study had some limitations. The sample size of
HCM patients (25 patients) is small but due to low
prevalence of HCM (0.2%). The assessment of LA
mass is a new idea not discussed before by any
imaging modalities. Of course it needs validation by
autopsy or magnetic resonance imaging but at least it
can pave a way for thinking about in further studies
either by the same or another formula. Assessment of
50 Int J Cardiovasc Imaging (2008) 24:45–52
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diastolic dysfunction was relied on transmitral flow
by pulsed wave Doppler and other parameters by
tissue Doppler imaging were not available. There are
no data about prognostic value of atrial remodelling
as a predictor for development of atrial fibrillation
because it need long time follow up for large sample
of patients. However data from previous studies
could be relied on [18, 19].
Conclusion
Hypertrophic cardiomyopathy is associated with
dilated LA and increased LAV that reflects the severity
of LA overload. Higher AA-SV and LA-KE in HCM
patients especially obstructive type indicates aug-
mented LA pump function to overcome the high left
ventricular filling pressure caused by severe left
ventricular hypertrophy. Lower PA-EF and AEI in
obstructive HCM patients indicate impaired LA res-
ervoir and conduit functions. These findings may have
clinical implication for the follow up of HCM patients
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